Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

1-Oxo Mirtazapine (Mirtazapine Impurity C)

1-Oxo Mirtazapine (Mirtazapine Impurity C) is listed in the pharmaceutical impurity collection under CAS 191546-96-0. Its represented structure has formula C17H17N3O and a calculated molecular weight of 279.34 g/mol.

2D chemical structure

N N N O

Chemical identity

Catalog name
1-Oxo Mirtazapine (Mirtazapine Impurity C)
Common name
1-Oxo Mirtazapine (Mirtazapine Impurity C)
Chemical name
Not available
CAS
191546-96-0
SMILES
CN1CCN2c3ncccc3Cc3ccccc3C2C1=O
InChI
InChI=1S/C17H17N3O/c1-19-9-10-20-15(17(19)21)14-7-3-2-5-12(14)11-13-6-4-8-18-16(13)20/h2-8,15H,9-11H2,1H3
InChIKey
NWXITVQAKIFZLZ-UHFFFAOYSA-N
Associated API
1-Oxo Mirtazapine (Mirtazapine

Record ID: Ae213dd0a9a4e

Computed properties

C17H17N3O Molecular formula
279.343 g/molMolecular weight
279.1372 DaMonoisotopic exact mass
36.44 ŲTopological polar surface area
2.0055 Calculated LogP (Wildman–Crippen)
81.209 cm³/molMolar refractivity (Wildman–Crippen)
3 countHydrogen-bond acceptors
0 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. 1 potential atom stereocenters have unspecified configuration.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 4 8 12 16 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight279.34337.98
Calculated LogP (Wildman–Crippen)2.005542.72
Topological polar surface area36.4417.91
Hydrogen-bond acceptors333.13
Hydrogen-bond donors011.28
Rotatable bonds (strict)03.45

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC17H17N3Odimensionless
Molecular weight279.343g/mol
Monoisotopic exact mass279.1372Da
Topological polar surface area36.44Ų
Calculated LogP (Wildman–Crippen)2.0055dimensionless
Molar refractivity (Wildman–Crippen)81.209cm³/mol
Hydrogen-bond acceptors3count
Hydrogen-bond donors0count
Rotatable bonds (strict)0count
Heavy atoms21count
Heteroatoms4count
Rings4count
Aromatic rings2count
Aliphatic rings2count
Saturated rings1count
Aromatic heterocycles1count
Aliphatic heterocycles2count
Saturated heterocycles1count
Aromatic carbocycles1count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.2941fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters1count
Unspecified atom stereocenters1count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area123.5673Ų
Valence electrons106count
Radical electrons0count
Bertz complexity712.6863index
Balaban J1.9537index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for 1-Oxo Mirtazapine (Mirtazapine Impurity C)

Qualification and safety assessment of 1-Oxo Mirtazapine (Mirtazapine Impurity C)

Explore toxicological qualification of 1-Oxo Mirtazapine (Mirtazapine Impurity C) and ICH M7 mutagenic impurity assessment of 1-Oxo Mirtazapine (Mirtazapine Impurity C) for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for 1-Oxo Mirtazapine (Mirtazapine Impurity C) and acceptable intake and limit justification for 1-Oxo Mirtazapine (Mirtazapine Impurity C). The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Other catalogue designations with the same represented structure

These are separate catalogue entries; shared structure does not establish interchangeable pharmacopoeial designations.

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for 1-Oxo Mirtazapine (Mirtazapine Impurity C)

Explore Altox services and software through the Altox Pharma-Hub.